Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer’s disease
Rent the article at a discount
Rent now* Final gross prices may vary according to local VAT.
Get AccessAbstract
Purpose
Amyloid imaging with 18F-labelled radiotracers will allow widespread use of this technique, facilitating research, diagnosis and therapeutic development for Alzheimer’s disease (AD). The purpose of this analysis was to compare data on cortical Aβ deposition in subjects who had undergone both 11C-PiB (PiB) and 18F-florbetaben (FBB) PET imaging.
Methods
We identified ten healthy elderly controls (HC) and ten patients with AD who had undergone PET imaging after intravenous injection of 370 MBq of PiB and 300 MBq of FBB under separate research protocols. PiB and FBB images were coregistered so that placement of regions of interest was identical on both scans and standard uptake value ratios (SUVR) using the cerebellar cortex as reference region were calculated between 40 and 70 min and between 90 and 110 min after injection for PiB and FBB, respectively.
Results
Significantly higher SUVR values (p < 0.0001) in most cortical areas were observed in AD patients when compared with HC with both radiotracers. Global SUVR values in AD patients were on average 75% higher than in HC with PiB and 56% higher with FBB. There was an excellent linear correlation between PiB and FBB global SUVR values (r = 0.97, p < 0.0001) with similar effect sizes for distinguishing AD from HC subjects for both radiotracers (Cohen’s d 3.3 for PiB and 3.0 for FBB).
Conclusion
FBB, while having a narrower dynamic range than PiB, clearly distinguished HC from AD patients, with a comparable effect size. FBB seems a suitable 18F radiotracer for imaging AD pathology in vivo.
- Villemagne, VL, Fodero-Tavoletti, MT, Pike, KE, Cappai, R, Masters, CL, Rowe, CC (2008) The ART of loss: abeta imaging in the evaluation of Alzheimer's disease and other dementias. Mol Neurobiol 38: pp. 1-15 CrossRef
- Rowe, CC, Ng, S, Ackermann, U, Gong, SJ, Pike, K, Savage, G (2007) Imaging beta-amyloid burden in aging and dementia. Neurology 68: pp. 1718-1725 CrossRef
- Klunk, WE, Engler, H, Nordberg, A, Wang, Y, Blomqvist, G, Holt, DP (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55: pp. 306-319 CrossRef
- Rabinovici, GD, Furst, AJ, O'Neil, JP, Racine, CA, Mormino, EC, Baker, SL (2007) 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology 68: pp. 1205-1212 CrossRef
- Fagan, AM, Mintun, MA, Mach, RH, Lee, SY, Dence, CS, Shah, AR (2006) Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta(42) in humans. Ann Neurol 59: pp. 512-519 CrossRef
- Bacskai, BJ, Frosch, MP, Freeman, SH, Raymond, SB, Augustinack, JC, Johnson, KA (2007) Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Arch Neurol 64: pp. 431-434 CrossRef
- Leinonen, V, Alafuzoff, I, Aalto, S, Suotunen, T, Savolainen, S, Nagren, K (2008) Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B. Arch Neurol 65: pp. 1304-1309 CrossRef
- Ikonomovic, MD, Klunk, WE, Abrahamson, EE, Mathis, CA, Price, JC, Tsopelas, ND (2008) Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain 131: pp. 1630-1645 CrossRef
- Chetelat, G, Villemagne, VL, Bourgeat, P, Pike, KE, Jones, G, Ames, D (2010) Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Ann Neurol 67: pp. 317-324
- Pike, KE, Savage, G, Villemagne, VL, Ng, S, Moss, SA, Maruff, P (2007) Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain 130: pp. 2837-2844 CrossRef
- Resnick, SM, Sojkova, J, Zhou, Y, An, Y, Ye, W, Holt, DP (2010) Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB. Neurology 74: pp. 807-815 CrossRef
- Villemagne, VL, Pike, KE, Chetelat, G, Ellis, KA, Mulligan, RS, Bourgeat, P (2011) Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease. Ann Neurol 69: pp. 181-192 CrossRef
- McKhann, GM, Knopman, DS, Chertkow, H, Hyman, BT, Jack, CR, Kawas, CH (2011) The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheim Dement 7: pp. 263-269 CrossRef
- Rowe, CC, Villemagne, VL (2011) Brain amyloid imaging. J Nucl Med 52: pp. 1733-1740 CrossRef
- Villemagne, VL, Rowe, CC (2010) Amyloid ligands for dementia. PET Clin 5: pp. 33-53 CrossRef
- Rowe, CC, Ackerman, U, Browne, W, Mulligan, R, Pike, KL, O'Keefe, G (2008) Imaging of amyloid beta in Alzheimer's disease with (18)F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurol 7: pp. 129-135 CrossRef
- Wong, DF, Rosenberg, PB, Zhou, Y, Kumar, A, Raymont, V, Ravert, HT (2010) In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (flobetapir F 18). J Nucl Med 51: pp. 913-920 CrossRef
- Vandenberghe, R, Laere, K, Ivanoiu, A, Salmon, E, Bastin, C, Triau, E (2010) 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial. Ann Neurol 68: pp. 319-329 CrossRef
- Jureus, A, Swahn, BM, Sandell, J, Jeppsson, F, Johnson, AE, Johnstrom, P (2010) Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand. J Neurochem 114: pp. 784-794 CrossRef
- Clark, CM, Schneider, JA, Bedell, BJ, Beach, TG, Bilker, WB, Mintun, MA (2011) Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA 305: pp. 275-283 CrossRef
- Barthel, H, Gertz, HJ, Dresel, S, Peters, O, Bartenstein, P, Buerger, K (2011) Cerebral amyloid-beta PET with florbetaben ((18)F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study. Lancet Neurol 10: pp. 424-435 CrossRef
- Ong, K, Villemagne, VL, Lamngon, N, Holl, G, Reininger, C, Putz B, B (2010) Assessment of Aβ deposition in mild cognitive impairment with 18F-florbetaben. Alzheim Dement 6: pp. S26 CrossRef
- Braak, H, Braak, E (1997) Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 18: pp. 351-357 CrossRef
- Villemagne, VL, Ong, K, Mulligan, RS, Holl, G, Pejoska, S, Jones, G (2011) Amyloid imaging with 18F-florbetaben in Alzheimer disease and other dementias. J Nucl Med 52: pp. 1210-1217 CrossRef
- McKhann, G, Drachman, D, Folstein, M, Katzman, R, Price, D, Stadlan, EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34: pp. 939-944
- Good, CD, Johnsrude, IS, Ashburner, J, Henson, RN, Friston, KJ, Frackowiak, RS (2001) A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14: pp. 21-36 CrossRef
- Ng, S, Villemagne, VL, Berlangieri, S, Lee, ST, Cherk, M, Gong, SJ (2007) Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease. J Nucl Med 48: pp. 547-552 CrossRef
- Aizenstein, HJ, Nebes, RD, Saxton, JA, Price, JC, Mathis, CA, Tsopelas, ND (2008) Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol 65: pp. 1509-1517 CrossRef
- Villemagne, VL, Pike, KE, Darby, D, Maruff, P, Savage, G, Ng, S (2008) Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease. Neuropsychologia 46: pp. 1688-1697 CrossRef
- Bennett, DA, Schneider, JA, Arvanitakis, Z, Kelly, JF, Aggarwal, NT, Shah, RC (2006) Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66: pp. 1837-1844 CrossRef
- Price, JL, Morris, JC (1999) Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 45: pp. 358-368 CrossRef
- Jack, CR, Lowe, VJ, Weigand, SD, Wiste, HJ, Senjem, ML, Knopman, DS (2009) Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 132: pp. 1355-1365 CrossRef
- Sojkova, J, Zhou, Y, An, Y, Kraut, MA, Ferrucci, L, Wong, DF (2011) Longitudinal patterns of beta-amyloid deposition in nondemented older adults. Arch Neurol 68: pp. 644-649 CrossRef
- Title
- Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer’s disease
- Journal
-
European Journal of Nuclear Medicine and Molecular Imaging
Volume 39, Issue 6 , pp 983-989
- Cover Date
- 2012-06-01
- DOI
- 10.1007/s00259-012-2088-x
- Print ISSN
- 1619-7070
- Online ISSN
- 1619-7089
- Publisher
- Springer-Verlag
- Additional Links
- Topics
- Keywords
-
- Alzheimer’s disease
- Amyloid imaging
- Aβ
- Positron emission tomography
- Industry Sectors
- Authors
-
- Victor L. Villemagne (1) (2) (3)
- Rachel S. Mulligan (1)
- Svetlana Pejoska (1)
- Kevin Ong (1)
- Gareth Jones (1)
- Graeme O’Keefe (1)
- J. Gordon Chan (1)
- Kenneth Young (1)
- Henri Tochon-Danguy (1)
- Colin L. Masters (3)
- Christopher C. Rowe (1) (2)
- Author Affiliations
-
- 1. Department of Nuclear Medicine and Centre for PET, Austin Health, 145 Studley Road, Heidelberg, VIC, 3084, Australia
- 2. Department of Medicine, University of Melbourne, Parkville, VIC, 3010, Australia
- 3. The Mental Health Research Institute of Victoria, Parkville, VIC, 3052, Australia